Obeidová L, Reiterová J, Lněnička P, Štekrová J, Šafránková H, Kohoutová M, Tesař V
Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic.
Folia Biol (Praha). 2012;58(4):173-6.
Blood filtration and formation of primary urine in the kidney glomerulus is provided by a specialized membrane called slit diaphragm located between well-branched pedicels of podocytes. Actually, the slit diaphragm is a protein supercomplex, whose disruption can cause failure of renal filtration, and patients usually manifest nephrotic syndrome. Recently, familial forms of nephrotic syndrome have been described which arise from malfunction of mutated proteins making up the slit diaphragm. In 2005 it was found that one of the proteins present in this complex was non-selective cation channel TRPC6. The aim of this work was to screen mutations and polymorphisms of the TRPC6 gene in a group of 64 Czech patients with nephrotic syndrome and subsequently, on the basis of these data, evaluate the role of mutations in the TRPC6 gene in Czech population. The analysis was performed by the PCR method followed by direct sequencing and high-resolution melting method. We have not identified any mutations in our group of patients. Two additional single nucleotide polymorphisms - p.P15S and p.A404V - were detected along with nucleotide changes that did not result in amino acid changes and with a few intronic changes. P.P15S heterozygotes were more frequent in patients with steroid-resistant FSGS than in steroid- sensitive patients (29 % versus 12.1 %). To conclude, we did not find any probable disease-causing mutation in the TRPC6 gene in the cohort of 64 Czech patients. The p.P15S polymorphism might have some influence on the therapeutic response of FSGS patients.
肾脏肾小球中的血液滤过和原尿形成是由一种位于足细胞高度分支的足突之间的特殊膜结构——裂孔隔膜实现的。实际上,裂孔隔膜是一种蛋白质超复合体,其破坏会导致肾脏滤过功能衰竭,患者通常表现为肾病综合征。最近,已经描述了一些家族性肾病综合征形式,它们源于构成裂孔隔膜的突变蛋白功能异常。2005年发现,该复合体中存在的一种蛋白质是非选择性阳离子通道TRPC6。这项工作的目的是在一组64名捷克肾病综合征患者中筛选TRPC6基因的突变和多态性,随后根据这些数据评估TRPC6基因突变在捷克人群中的作用。分析采用聚合酶链反应(PCR)方法,随后进行直接测序和高分辨率熔解分析。我们在患者组中未发现任何突变。检测到另外两个单核苷酸多态性——p.P15S和p.A404V,以及未导致氨基酸变化的核苷酸变化和一些内含子变化。与激素敏感患者相比,激素抵抗型局灶节段性肾小球硬化症(FSGS)患者中p.P15S杂合子更为常见(29%对12.1%)。总之,在64名捷克患者队列中,我们未在TRPC6基因中发现任何可能致病的突变。p.P15S多态性可能对FSGS患者的治疗反应有一定影响。